Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xcopri
Pharma
SK settles with MSN over generic of seizure med Xcopri: reports
SK has struck a settlement with generics manufacturer MSN, which will allow the Korean company to extend its market exclusivity beyond 2032 for Xcopri.
Kevin Dunleavy
Aug 19, 2026 11:21am
SK Life Science Xcopri ad meets a roadblock with FDA letter
Nov 24, 2025 12:00pm
BMS JV sale, biotech debuts, possible deals—Fierce Pharma Asia
Sep 19, 2025 8:36am
Daiichi Sankyo, Glenmark, Serum-Biocon—Fierce Pharma Asia
Apr 28, 2023 8:35am
SK brings rainstorm to neurology event to push epilepsy drug
Apr 24, 2023 9:05am
J&J-Legend, Junshi, Vir-WuXi and more—Fierce Pharma Asia
May 27, 2022 9:53am
